CIK 0001498382
- Non-accelerated filer
- Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 990360497
- Phone
- +1 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-01 | Praill Anthony Scott Chief Financial Officer | Grant or award | +240,087 | 277,273 | ||
| 2022-08-01 | Praill Anthony Scott Chief Financial Officer | Grant or award · Option (right to buy) | +720,260 | 720,260 | ||
| 2021-12-08 | Praill Anthony Scott Chief Financial Officer | Purchase | +28,700 | $0.68 | $19K | 37,186 |
| 2021-04-29 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +8 | 7,548 | ||
| 2021-04-29 | Praill Anthony Scott Chief Financial Officer | Conversion | +938 | 8,486 | ||
| 2021-04-29 | Praill Anthony Scott Chief Financial Officer | Conversion · Series B Convertible Preferred Stock | −3,750 | 0 | ||
| 2021-03-31 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +22 | 7,540 | ||
| 2020-12-31 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +22 | 7,518 | ||
| 2020-09-30 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +22 | 7,496 | ||
| 2020-09-15 | Praill Anthony Scott Chief Financial Officer | Grant or award · Options (Right to Buy) | +606,557 | 606,557 | ||
| 2020-06-30 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +22 | 7,474 | ||
| 2020-06-26 | Praill Anthony Scott Chief Financial Officer | Grant or award · Option (Right to Buy) | +57,170 | 108,366 | ||
| 2020-03-31 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +22 | 7,452 | ||
| 2019-12-31 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +22 | 7,430 | ||
| 2019-09-30 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +22 | 7,408 | ||
| 2019-09-05 | Praill Anthony Scott Chief Financial Officer | Grant or award · Options (Right to Buy) | +57,170 | 57,170 | ||
| 2019-09-05 | Praill Anthony Scott Chief Financial Officer | Grant or award · Options (Right to Buy) | +51,196 | 51,196 | ||
| 2019-06-28 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +22 | 7,386 | ||
| 2019-03-29 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +211 | $0.49 | $103 | 73,632 |
| 2018-12-31 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +211 | $0.34 | $72 | 73,421 |
Page 1 of 2 · 27 trades